Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 60,619	$ 40,110
Accounts receivable, net	74,270	69,503
Inventories, net	124,158	145,736
Income taxes receivable	6,158	11,374
Current derivative financial instruments		22,578
Other current assets	18,819	19,460
Total current assets	284,024	308,761
Property, plant and equipment, net	274,039	329,892
Deferred income tax assets, net	2	39,046
Intangibles, net	4,516	12,612
Derivative financial instruments		14,736
Other noncurrent assets	29,388	35,082
Total assets	591,969	740,129
Current liabilities:
Accounts payable	75,216	120,351
Short-term debt	631,430	7,939
Accrued expenses	55,104	65,731
Income taxes payable	367	1,905
Total current liabilities	762,117	195,926
Long-term debt (less current portion)	524	481,449
Noncurrent income tax liabilities	3,003	5,341
Deferred income tax liabilities, net	0	1,105
Other noncurrent liabilities	38,253	43,581
Commitments and contingent liabilities (Note 15)
Mezzanine equity:
Preferred stock, $0.01 par value Authorized - 1,000,000 shares Issued and outstanding - 150,000 shares outstanding at September 30, 2025 and December 31, 2024	335,800	288,465
Noncontrolling redeemable equity	523	480
Shareholders' equity (deficit):
Common stock, $0.01 par value Authorized - 100,000,000 shares Issued and outstanding - 37,298,422 and 28,886,053 shares at September 30, 2025 and December 31, 2024	125,231	123,039
Accumulated other comprehensive income (loss)	(46,986)	(98,471)
Retained earnings (deficit)	(626,496)	(300,786)
Total shareholders' equity (deficit)	(548,251)	(276,218)
Total liabilities, mezzanine equity and shareholders' equity (deficit)	$ 591,969	$ 740,129